The Covid-19 biosurveillance programme was initially introduced in September last year. Credit: Skitterphoto / Pixabay.

The Centers for Disease Control and Prevention (CDC) in the US has extended its collaboration with XpresSpa Group’s subsidiary XpresCheck for the Covid-19 biosurveillance programme at airports.

The extension increases the contract value from the initial level of $2m to $5.6m.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Covid-19 biosurveillance programme was initially introduced in September last year.

It includes an eight-week pilot that focuses on the importation of emerging SARS-CoV-2 variants in the US on flights originating from India.

XpresCheck CEO Ezra Ernst said: “During the Thanksgiving holiday, we worked closely with the CDC to pivot and expand our surveillance programme to screen for the new, highly contagious Omicron variant that was identified just days earlier in Africa.

“Together, with our testing partner, Concentric by Ginkgo, we successfully expanded the programme to monitor additional flights from around the globe.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

With this extension, passengers arriving from seven African nations, including those making connections through the UK, France, Germany and Brazil, will be tested under the programme.

Earlier, the programme included three US airports, namely John F Kennedy International Airport (JFK), Newark-Liberty International Airport (EWR) and San Francisco International Airport (SFO).

With the inclusion of Hartsfield-Jackson Atlanta International Airport (ATL), the number of testing sites has now increased to four.

Operationally, the current expansion will include the same tests and procedures as the pilot programme.

Under the programme, travellers take a PCR test, which is sent to the lab with additional samples to identify the presence of Covid-19.

If confirmed, the viral samples undergo genomic sequencing for the identification of the present variant.

Airport Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Airport Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Klayo’s talent and compliance platform tailored for airports has secured the Innovation Award in the Workforce Digitalization category . Learn how its competency gap analysis, integrated compliance hub and data-driven workforce planning are helping airports streamline operations, strengthen governance and engage employees.

Discover the Impact